4//SEC Filing
Ho Carole 4
Accession 0001714899-25-000026
CIK 0001714899other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 6:56 PM ET
Size
9.3 KB
Accession
0001714899-25-000026
Insider Transaction Report
Form 4
Ho Carole
Chief Medical Officer
Transactions
- Award
Common Stock
2025-01-03+54,180→ 190,835 total - Award
Stock Option (right to buy)
2025-01-03+162,540→ 162,540 totalExercise: $21.26Exp: 2035-01-02→ Common Stock (162,540 underlying)
Holdings
- 183,219(indirect: See footnote)
Common Stock
- 25,000(indirect: See footnote)
Common Stock
Footnotes (5)
- [F1]Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2026 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.
- [F2]Includes 141,530 Unvested RSUs.
- [F3]The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.
- [F4]The shares are held of record by The Rohatgi-Ho Irrevocable GST Trust for the benefit of the Reporting Person's children.
- [F5]25% of the shares subject to the option shall vest on January 3, 2026, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.
Documents
Issuer
Denali Therapeutics Inc.
CIK 0001714899
Entity typeother
Related Parties
1- filerCIK 0001724605
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 6:56 PM ET
- Size
- 9.3 KB